CompletedNCT00382291
Sertraline dose schedules with cognitive behavioral therapy for OCD
About this title
Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder
Read the official source — NCT00382291Medication studyAges 7–17United States
Understand this study
Who was this study for?
Listed age limits: 7 years to 17 years.
- Listed locations
- Gainesville and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateFebruary 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 56
- Sponsor
- University of Florida
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 7 Years to 17 Years
- Official registry ID
- NCT00382291
- Official title
Show the full official title
SSRI-Induced Activation Syndrome in Pediatric Obsessive Compulsive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Gainesville · Tampa
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Florida, a university.
Did this study involve medication?
Yes. The study involved medication, including Regular Titration, Placebo and Slow Titration.
Who was this study for?
Listed age limits: 7 years to 17 years.
